Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | ATAD2 | Q6PL18 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | CASP1 | P29466 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 3/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.35 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.35 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30740061 | 0.98 | LMNA (0.38) | LMNASMN1; SMN2ATAD2TSHRHTT | |
| SCHEMBL4146947 | 0.77 | CASP6 (0.41) | ATAD2KDM4EALDH1A1MAPTPOLB | |
| SCHEMBL21026204 | 0.77 | AURKA (0.33) | ATAD2AURKATTKAURKBINCENP | |
| SCHEMBL4621367 | 0.75 | — | — | |
| SCHEMBL566202 | 0.71 | GAA (0.43) | LMNASMN1; SMN2TSHRHTTKDM4E | |
| SCHEMBL1689852 | 0.71 | LMNA (0.39) | LMNASMN1; SMN2TSHRHTTKDM4E | |
| SCHEMBL3189250 | 0.71 | TSHR (0.44) | LMNASMN1; SMN2TSHRHTTKDM4E | |
| SCHEMBL3806350 | 0.71 | ERN1 (0.42) | LMNASMN1; SMN2TSHRHTTKDM4E | |
| SCHEMBL1527119 | 0.71 | TSHR (0.39) | LMNASMN1; SMN2TSHRHTTKDM4E | |
| SCHEMBL24566757 | 0.71 | ALDH1A1 (0.38) | LMNASMN1; SMN2ATAD2TSHRHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5830867-A | Hemoregulatory peptides for stimulating the myelopoietic system | SMITHKLINE BEECHAM CORPORATION (US) | 1998-11-03 | — | — | US | claimed |
| EP-0701446-A4 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORP (US) | 1997-04-23 | — | — | EP | claimed |
| EP-0701446-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1996-03-20 | — | — | EP | claimed |
| WO-1994027627-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1994-12-08 | — | — | WO | claimed |
| US-20260022280-A1 | LOW VOC SOLVENT CEMENT FORMULATION WITH REDUCED TOXICITY AND RAPID CURING | KOKKOT RANJITH (IN) | 2026-01-22 | — | — | US | disclosed |
| CN-119978546-A | Solid organic tin composite heat stabilizer technological formula | 宁夏睿欣科技发展有限公司 | 2025-05-13 | — | — | CN | disclosed |
| WO-2023150592-A2 | N3-SUBSTITUTED URACIL COMPOUNDS AS TRPA1 INHIBITORS | D.E. SHAW RESEARCH, LLC (US) | 2023-08-10 | — | — | WO | disclosed |
| US-11708336-B2 | Anodic oxidation of 5-aminouracil | MEDIBEACON INC. (US) | 2023-07-25 | — | — | US | disclosed |
| CN-109232443-B | Pyrimidone derivatives, preparation method and medical application thereof | 中国药科大学 | 2022-03-08 | — | — | CN | disclosed |
| EP-3272754-B1 | IMIDAZOPYRROLIDINONE COMPOUNDS | NOVARTIS AG (CH) | 2019-05-29 | — | — | EP | disclosed |
| EP-3272754-B1 | IMIDAZOPYRROLIDINONE COMPOUNDS | NOVARTIS AG (CH) | 2019-05-29 | — | — | EP | disclosed |
| CN-109232443-A | Pyrimidone derivatives, preparation method and medical usage | 中国药科大学 | 2019-01-18 | — | — | CN | disclosed |
| CN-1492870-A | Xanthine derivatives, process for their preparation and their use as pharmaceutical compositions | ���ָ��Ӣ��ķ�������Ϲ�˾ | 2004-04-28 | — | — | CN | disclosed |
| EP-1406962-A1 | USE OF AMINOURACILS FOR STABILISING ANTISTATIC ORGANIC PLASTICS CONTAINING HALOGEN | Cognis Deutschland GmbH & Co. KG (DE) | 2004-04-14 | — | — | EP | disclosed |
| WO-2003056061-A2 | POLYMER DERIVATIVES FOR THE TREATMENT OF METALS | BASF AKTIENGESELLSCHAFT (DE) | 2003-07-10 | — | — | WO | disclosed |
| WO-2003004556-A1 | USE OF AMINOURACILS FOR STABILISING ANTISTATIC ORGANIC PLASTICS CONTAINING HALOGEN | COGNIS DEUTSCHLAND GMBH & CO. KG (DE) | 2003-01-16 | — | — | WO | disclosed |
| US-5830867-A | Hemoregulatory peptides for stimulating the myelopoietic system | SMITHKLINE BEECHAM CORPORATION (US) | 1998-11-03 | — | — | US | disclosed |
| EP-0701446-A4 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORP (US) | 1997-04-23 | — | — | EP | disclosed |
| EP-0701446-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1996-03-20 | — | — | EP | disclosed |
| WO-1994027627-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1994-12-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11708336-B2 | Anodic oxidation of 5-aminouracil | DPYD, DHODH, AASDHPPT | LMNA 3508/4885SMN1; SMN2 2424/4885ATAD2 960/4885 |
| US-20260022280-A1 | LOW VOC SOLVENT CEMENT FORMULATION WITH REDUCED TOXICITY AND RAPID CURING | JMJD1C, KDM5C, SUV39H2 | LMNA 3002/4885SMN1; SMN2 2573/4885ATAD2 2153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.